Loading...
SIGA Technologies, Inc.
SIGA•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$7.01
$-0.20(-2.77%)
SIGA Technologies, Inc. (SIGA) Financial Performance & Income Statement Overview
Review SIGA Technologies, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-0.86%
↓ 0.86%
Operating Income Growth
-16.31%
↓ 16.31%
Net Income Growth
-13.01%
↓ 13.008%
Operating Cash Flow Growth
-48.56%
↓ 48.56%
Operating Margin
46.91%
↑ 46.91%
Gross Margin
70.89%
↑ 70.89%
Net Profit Margin
40.33%
↑ 40.33%
ROE
25.24%
↑ 25.24%
ROIC
25.75%
↑ 25.75%
SIGA Technologies, Inc. (SIGA) Income Statement & Financial Overview
Review SIGA Technologies, Inc.'s (SIGA) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $7.04M | $81.47M | $10.010M | $21.81M |
| Cost of Revenue | $3.62M | $17.48M | $1.62M | $12.31M |
| Gross Profit | $3.42M | $63.99M | $8.39M | $9.50M |
| Gross Profit Ratio | $0.49 | $0.79 | $0.84 | $0.44 |
| R&D Expenses | $1.22M | $0.00 | $1.07M | $2.89M |
| SG&A Expenses | $5.68M | $6.91M | $4.82M | $5.53M |
| Operating Expenses | $5.68M | $6.91M | $7.85M | $8.42M |
| Total Costs & Expenses | $9.30M | $24.38M | $9.47M | $20.73M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $135308.00 | $130729.00 | $0.00 | $140839.00 |
| EBITDA | -$2.12M | $57.22M | $542087.00 | $1.22M |
| EBITDA Ratio | -$0.30 | $0.70 | $0.05 | $0.06 |
| Operating Income | -$2.26M | $57.09M | $542087.00 | $1.08M |
| Operating Income Ratio | -$0.32 | $0.70 | $0.05 | $0.05 |
| Other Income/Expenses (Net) | $1.68M | $1.50M | $1.33M | $1.32M |
| Income Before Tax | -$570415.00 | $58.58M | $1.87M | $2.40M |
| Income Before Tax Ratio | -$0.08 | $0.72 | $0.19 | $0.11 |
| Income Tax Expense | -$162000.00 | $12.82M | $528647.00 | $565219.00 |
| Net Income | -$408223.00 | $45.76M | $1.34M | $1.83M |
| Net Income Ratio | -$0.06 | $0.56 | $0.13 | $0.08 |
| EPS | -$0.01 | $0.64 | $0.02 | $0.03 |
| Diluted EPS | -$0.01 | $0.64 | $0.02 | $0.03 |
| Weighted Avg Shares Outstanding | $71.43M | $71.25M | $71.37M | $71.15M |
| Weighted Avg Shares Outstanding (Diluted) | $71.43M | $71.77M | $71.77M | $71.75M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan